John Scrivener

Title: Innovations of John Scrivener in Ophthalmic Lens Technology

Introduction

John Scrivener is an accomplished inventor based in Jacksonville, FL (US), known for his significant contributions to the field of ophthalmic lens technology. With a total of two patents to his name, Scrivener has developed innovative methods that enhance vision correction through multifocal lenses.

Latest Patents

Scrivener's latest patents include a "Method of manufacturing a segmented multifocal ophthalmic lens" and a "Segmented multifocal contact lens." The first patent describes a method for creating multifocal refractive contact lenses that focus light on the retina. This method utilizes alternating segments with different optical powers for distance and near vision, eliminating the need for lens orientation. The design incorporates aspherical lens surfaces and features segments divided by an arcuate path, allowing for interchangeable molds that facilitate the manufacturing process. The second patent further elaborates on the multifocal refractive lens, emphasizing its ability to provide adequate vision without orientation and highlighting the innovative use of aspherical surfaces.

Career Highlights

Scrivener is currently associated with Johnson & Johnson Vision Products Inc., where he continues to push the boundaries of lens technology. His work has significantly impacted the way multifocal lenses are designed and manufactured, improving the quality of life for individuals requiring vision correction.

Collaborations

Throughout his career, Scrivener has collaborated with notable colleagues, including Jeffrey H. Roffman and Edgar V. Menezes. These partnerships have fostered a creative environment that encourages innovation and the development of cutting-edge optical solutions.

Conclusion

John Scrivener's contributions to ophthalmic lens technology exemplify the spirit of innovation in the field. His patents reflect a commitment to enhancing vision correction methods, making a lasting impact on the industry.